Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases
Longwei Zhao(China Pharmaceutical University), Zhifeng Huang(Wenzhou Medical University)
Cited by 29
Related Papers
FGF1ΔHBS prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK/Nur77 suppression
|Signal Transduction and Targeted Therapy|2021|130
FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation
|Cell Death and Disease|2019|98
A Novel Solid-Phase Site-Specific PEGylation Enhances the In Vitro and In Vivo Biostabilty of Recombinant Human Keratinocyte Growth Factor 1
|PLoS ONE|2012|29
Fibroblast growth factor 1 ameliorates adipose tissue inflammation and systemic insulin resistance via enhancing adipocyte mTORC2/Rictor signal
|Journal of Cellular and Molecular Medicine|2020|22